Membrane-anchored	JJ
Serine	NN
Protease	NN
Matriptase	NN
Is	VBZ
a	DT
Trigger	NN
of	IN
Pulmonary	JJ
Fibrogenesis	NN
.	.

RATIONALE	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
devastating	JJ
disease	NN
that	WDT
remains	VBZ
refractory	JJ
to	TO
current	JJ
therapies	NNS
.	.

OBJECTIVES	NNS
:	:
To	TO
characterize	VB
the	DT
expression	NN
and	CC
activity	NN
of	IN
the	DT
membrane-anchored	JJ
serine-protease	NN
matriptase	NN
in	IN
IPF	NN
in	IN
humans	NNS
and	CC
unravel	VB
its	PRP$
potential	JJ
role	NN
in	IN
human	JJ
and	CC
experimental	JJ
pulmonary	JJ
fibrogenesis	NN
.	.

METHODS	NNS
:	:
Matriptase	NN
expression	NN
was	VBD
assessed	VBN
in	IN
tissue	NN
specimens	NNS
from	IN
patients	NNS
with	IN
IPF	NN
versus	CC
control	NN
subjects	NNS
using	VBG
quantitative	JJ
reverse	JJ
transcriptase-polymerase	NN
chain	NN
reaction	NN
,	,
immunohistochemistry	NN
,	,
and	CC
Western	NN
blotting	NN
,	,
while	IN
matriptase	NN
activity	NN
was	VBD
monitored	VBN
by	IN
fluorogenic	JJ
substrate	NN
cleavage	NN
.	.

Matriptase-induced	JJ
fibroproliferative	JJ
responses	NNS
and	CC
the	DT
receptor	NN
involved	VBN
were	VBD
characterized	VBN
in	IN
human	JJ
primary	JJ
pulmonary	JJ
fibroblasts	NNS
by	IN
Western	NN
blot	NN
,	,
viability	NN
,	,
and	CC
migration	NN
assays	NNS
.	.

In	IN
the	DT
murine	JJ
model	NN
of	IN
bleomycin-induced	JJ
pulmonary	JJ
fibrosis	NN
,	,
the	DT
consequences	NNS
of	IN
matriptase	NN
depletion	NN
,	,
either	CC
by	IN
using	VBG
the	DT
pharmacological	JJ
inhibitor	NN
camostat	NN
mesilate	NN
(	(
CM	NN
)	)
,	,
or	CC
by	IN
genetic	JJ
down-regulation	NN
using	VBG
matriptase	NN
hypomorphic	JJ
mice	NNS
,	,
were	VBD
characterized	VBN
by	IN
quantification	NN
of	IN
secreted	VBN
collagen	NN
and	CC
immunostainings	NNS
.	.

MEASUREMENTS	NNS
AND	CC
MAIN	NNS
RESULTS	NNS
:	:
Matriptase	NN
expression	NN
and	CC
activity	NN
were	VBD
up-regulated	VBN
in	IN
IPF	NN
and	CC
bleomycin-induced	JJ
pulmonary	JJ
fibrosis	NN
.	.

In	IN
cultured	VBN
human	JJ
pulmonary	JJ
fibroblasts	NNS
,	,
matriptase	NN
expression	NN
was	VBD
significantly	RB
induced	VBN
by	IN
transforming-growth-factor-b	NN
.	.

Furthermore	RB
,	,
matriptase	NN
elicited	VBD
signaling	NN
via	IN
protease-activated-receptor-2	NN
(	(
PAR-2	NN
)	)
,	,
and	CC
promoted	VBD
fibroblast	NN
activation	NN
,	,
proliferation	NN
,	,
and	CC
migration	NN
.	.

In	IN
the	DT
experimental	JJ
bleomycin	NN
model	NN
,	,
matriptase	NN
depletion	NN
,	,
by	IN
the	DT
pharmacological	JJ
inhibitor	NN
CM	NN
or	CC
by	IN
genetic	JJ
down-regulation	NN
,	,
diminished	VBD
lung	NN
injury	NN
,	,
collagen	NN
production	NN
,	,
and	CC
transforming-growth-factor-b	JJ
expression	NN
and	CC
signaling	NN
.	.

CONCLUSIONS	NNS
:	:
These	DT
results	NNS
implicate	VBP
increased	VBN
matriptase	NN
expression	NN
and	CC
activity	NN
in	IN
the	DT
pathogenesis	NN
of	IN
pulmonary	JJ
fibrosis	NN
in	IN
human	JJ
IPF	NN
and	CC
in	IN
an	DT
experimental	JJ
mouse	NN
model	NN
.	.

Overall	RB
,	,
targeting	VBG
matriptase	NN
,	,
or	CC
treatment	NN
by	IN
CM	NN
,	,
which	WDT
is	VBZ
already	RB
in	IN
clinical	JJ
use	NN
for	IN
other	JJ
diseases	NNS
,	,
may	MD
represent	VB
potential	JJ
therapies	NNS
for	IN
IPF	NN
.	.

